Moderna forecasts 15% to 25% 2026 revenue growth as it targets $8.1B to $8.3B year-end cash (NASDAQ:MRNA)
· seekingalpha.com
Moderna Q3 2026 earnings: revenue rose 29%, guidance was raised, and oncology updates advanced.
Earnings Call Insights Moderna forecasts 15% to 25% 2026 revenue growth as it targets $8.1B to $8.3B year-end cash Nov 06, 2026, 3:26 PM ET Moderna, Inc. (MRNA)...